Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (2121)	3/25/1999 2:06:00 PM
From: Don Miller	Respond to of 10280

Maybe I'm missing something, you are far better at this than I. I would expect to also see LLY rise on FDA label approval. I mentioned ABT because is was tracking SEPR better than LLY was. SEPR has risen ~3.5% today yet LLY has stayed flat to lower. I read this as a lack of any new leaks regarding a label approval (especially good new). Probably means even no label notice today at all. ie. this SEPR rise is pure naked strength, recovering from an oversold position. OR a buy on rumor surge.